Is XWELL, Inc. a real, registered company?
XWELL, Inc. is a registered filer with the SEC (CIK 1410428) and has filed since 2025-01-28. 2 filings are on record, the latest on 2026-03-03.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
How much has XWELL, Inc. raised?
Its new offerings report $35M sold across 2 offerings, as its own filings state.
Run the free check on XWELL, Inc. →
NEW YORK, NEW YORK
Other Health Care
2
$35M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-03-03 | New offering first sale 2026-02-27 | $31M | $31M | SEC filing |
| 2025-01-28 | New offering first sale 2025-01-14 | $4M | $4M | SEC filing |
Keep reading
More on XWELL, Inc. and the records around it.
The people at XWELL, Inc.
- Bruce Bernstein is also named on 4 other Form D filings: TNF Pharmaceuticals, Inc. (Sep 2025), Synaptogenix, Inc. (Jun 2025)
- Robert Weinstein is also named on 2 other Form D filings: Synaptogenix, Inc. (Jun 2025)
XWELL, Inc. elsewhere on the record
- 5%+ stake filings Sep 2026
- Leadership changes Aug 2026
- Form D filing Mar 2026
- Who owns it
Companies that share a holder
- Iroquois Capital Management, LLC also filed stake reports on 13 other companies: 22nd Century Group (Aug 2026), Clearmind Medicine Inc. (Aug 2026), SCWorx Corp. (Aug 2026)
Watch XWELL, Inc.
Get an email when XWELL, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with XWELL, Inc.?
Who to contact
- Ezra Ernst — President and Chief Executive Officer and Director
- Thomas Brown — Chief Financial Officer
- Bruce Bernstein — Chairman of the Board
- Robert Weinstein — Director
- Gaelle Wizenberg — Director
- Michael Lebowitz — Director
- Round: Form D filed 2026-03-03
- Amount sold: $31M
- Industry: Other Health Care
- Based: NEW YORK, NEW YORK
People listed
- Ezra Ernst — President and Chief Executive Officer and Director
- Thomas Brown — Chief Financial Officer
- Bruce Bernstein — Chairman of the Board
- Robert Weinstein — Director
- Gaelle Wizenberg — Director
- Michael Lebowitz — Director
- Filing: Form D filed 2026-03-03
- Amount sold: $31M
- Industry group: Other Health Care
- Based: NEW YORK, NEW YORK
- Entity type: Corporation
We'll show it in your MentionFox inbox when XWELL, Inc. raises, hires or launches. No email unless you switch it on.
Watch XWELL, Inc. →Want the whole picture on XWELL, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on XWELL, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on XWELL, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from XWELL, Inc.'s own filings with the SEC. The people those filings name are on the team page.